Baofeng Pharmaceutical

Beijing Baofeng Pharmaceutical is a specialized biopharmaceutical company focused on the development of therapeutics for neurological and cerebrovascular diseases. The company is a leader in the research of Nervonic Acid, a critical component for brain health and myelin sheath repair, derived from the Acer truncatum tree. Its flagship product, Antiepilepsirine (AES), is a recognized treatment for epilepsy in China. Baofeng integrates botanical cultivation, high-purity extraction, and pharmaceutical manufacturing to provide solutions for conditions such as Alzheimer's, Parkinson's, and pediatric epilepsy. The company operates as a key subsidiary within the Genesis Healthcare Holdings group, leveraging modern biotechnology to modernize traditional medicinal compounds.